C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A117.0 KBCinCor Pharma, Inc.Mar 3, 10:06 AM ET·0001104659-23-028265
- SC 13D/A138.0 KBCinCor Pharma, Inc.Mar 1, 1:38 PM ET·0001104659-23-027226
- SC 13D/A149.6 KBCinCor Pharma, Inc.Feb 28, 4:30 PM ET·0001104659-23-026754
- SC 13D/A241.7 KBCinCor Pharma, Inc.Feb 28, 4:16 PM ET·0000950142-23-000537
- 8-K281.7 KBCinCor Pharma, Inc.Feb 24, 9:19 AM ET·0001193125-23-047746
- 8-K170.7 KBCinCor Pharma, Inc.Feb 21, 8:51 AM ET·0001193125-23-043031
- SC 13G65.0 KBCinCor Pharma, Inc.Feb 14, 2:30 PM ET·0001193125-23-038710
- SC 13D151.6 KBCinCor Pharma, Inc.Feb 13, 1:33 PM ET·0001104659-23-019448
- SC 13G/A103.6 KBCinCor Pharma, Inc.Feb 9, 8:33 AM ET·0000902664-23-001313
- SC 13D183.2 KBCinCor Pharma, Inc.Jan 18, 4:00 PM ET·0001104659-23-004590
Insiders
10- 5AM Opportunities I (GP), LLC10% Owner
- 5AM Opportunities II (GP), LLC10% Owner
- 5AM Opportunities I, L.P.10% Owner
- 5AM Partners VI, LLC10% Owner
- 5AM Ventures VI, L.P.10% Owner
- Allison David D.Director
- Bhaman MainaDirector
- CinRx Pharma, LLC10% Owner
- Coelho Mary TheresaEVP CFO & Chief BD Officer
- de Garidel MarcDirector, Chief Executive Officer
Tickers
No tickers on record
Addresses
business
230 THIRD AVE., 6TH FLOOR
WALTHAM, MA, 02451
mailing
230 THIRD AVE., 6TH FLOOR
WALTHAM, MA, 02451